Childhood Cancer Research News
Meet the people who are behind the scenes, doing the groundbreaking work that will lead to improved outcomes, safer treatments, and eventually a cure for pediatric cancer. They may not be famous, but for the children and families facing a tough, sometimes seemingly impossible battle against childhood cancer, the people behind the research offer hope for a cancer-free future. They are their heroes.
Behind the Science Q & A with Dr. Elliot Stieglitz
We'd like you to meet Dr. Elliot Stieglitz. Dr. Stieglitz is innovative in discovering new targeted therapies for patients with Juvenile myelomonocytic leukemia also called JMML, a type of blood cancer that affects infants and young children.
Behind the Science: Q & A with Dr. Sarah Injac
We'd like you to meet Dr. Sarah Injac. Her research offers hope to children with Medulloblastoma, the most common malignant brain tumor in children.
Behind the Science: Q & A with Dr. Ting Tao
We’d like you to meet Dr. Ting Tao, Emerging Investigator from Dana-Farber Cancer Institute. His research focuses on developing new treatments for neuroblastoma.
Behind the Science: Q & A with Dr. Lingling Chen
Funding Lifesaving Research with Dr. Lingling Chen We'd like you to meet Dr. Lingling Chen, Emerging Investigator Grant recipient from Johns Hopkins University School of Medicine. This type of grant is designed for emerging pediatric
Women in Science: PCRF Funded Researchers Who Are Leading the Way
In honor of Women in Science Day, the Pediatric Cancer Research Foundation would like to proudly recognize some of the brilliant women funded by PCRF who are leading the way in their fields and working to cure pediatric cancer.
Pediatric Cancer Research Foundation Funds 9 New Research Grants in 2019
Press Release - IRVINE, CA (April 3, 2018) –On Saturday and Sunday, Mar. 24 and 25, the 20th Anniversary Reaching for the Cure Half Marathon, 10K, 5K and Kids Run race weekend was held on the Irvine Valley College campus with contributions totaling over $525,000 to help reach for a cure for pediatric cancer.
Behind the Science: Q & A with Dr. Sampurna Chatterjee
We’d like you to meet Dr. Sampurna Chatterjee, Emerging Investigator Grant recipient from Massachusetts General Hospital. Dr. Chatterjee explores reducing side effects of Medulloblastoma, the most common brain tumor in children.
Behind the Science: Q & A with Dr. Alex Huang
We’d like you to meet Dr. Alex Huang, Basic Research Science Grant recipient from Case Western Reserve University. Dr. Alex Huang has been a longtime recipient of PCRF grant funding.
Behind the Science: Q & A with Dr. Michael Ortiz
We'd like you to meet Dr. Michael Ortiz, Emerging Investigator Grant recipient. Dr. Ortiz's hope is to improve the way we care for patients with Wilms tumor, the most common childhood kidney cancer.
Behind the Science: Q & A with Dr. Kathleen Sakamoto
We'd like you to meet Dr. Kathleen Sakamoto, Translational Research Grant recipient. Dr. Sakamoto's hope is to improve the overall survival of children with relapsed leukemia so that they will live healthy and productive lives.
Dr. Alex Huang Receives $450,000 Grant from PCRF
Leading cancer researcher, Alex Huang MD, PhD, has received a $450,000 Basic Science grant from Pediatric Cancer Research Foundation to study targeted approaches for effectively eliminating metastatic osteosarcoma.
PCRF Funds SIX New Research Grants in 2018
Thanks to your generous support, Pediatric Cancer Research Foundation is able to fund 6 new, promising research grants in 2018!
Behind the Science: Q & A with Dr. Rishi Lulla and Dr. Amanda Saratsis
Meet Dr. Rishi Lulla and Dr. Amanda Saratsis who are improving treatment options for children with DIPG and other pediatric brain tumors.
Behind the Science: Q & A with Dr. Anat Erdreich-Epstein
Meet Dr. Anat Erdreich-Epstein, Translational Research Grant recipient from Children's Hospital Los Angeles. Her focus in this grant is to better understand the biology of medulloblastomas, the most common malignant brain tumors in children, in order to find new ways to approach its treatment.
Behind the Science: Q & A with Dr. Monika Davare
Meet Dr. Monika Davare, PCRF Emerging Researcher working hard to make a difference in the lives of children fighting cancer.
Leukemia Research Could Change Treatment Options
PCRF supported researcher, Jessica Heath at University of Vermont is helping to lead the way in cutting edge Leukemia research with recent breakthrough.
Children’s Hospitals Plan Strategic Affiliation
Mattel and Miller Children's Hospitals - two leading children's hospitals announced their intent to form a strategic affiliation.
Carousel of Possible Dreams Event to Benefit PCRF
PCRF plans to fund DIPG research at Lurie Children's Hospital from funds raised from Carousel of Possible Dreams event on August 12.
4-Star Rating Awarded to PCRF for 4th Consecutive Year
Pediatric Cancer Research Foundation's commitment to accountability and transparency have earned it a 4-star rating from Charity Navigator.
Give Back Partner Highlight: Cellar Angels
With every wine purchase, select PCRF as the cause you want to support. Cellar Angels will then donate 10% of the sales proceeds to PCRF!
PCRF Opens College Scholarship Application for Pediatric Cancer Survivors
Pediatric Cancer Research Foundation will award a college scholarship to up to four students who have been affected by pediatric cancer.
PCRF FUNDS 13 RESEARCH GRANTS IN 2017
Pediatric Cancer Research Foundation is committing $1.7 million to fund new research grants at leading institutions across the country
U.S. NEWS RANKS BEST CHILDREN’S HOSPITALS
U.S. News & World Report has released its 2016-17 Best Children's Hospitals rankings.
Dr. Wei Li
Penn State College of Medicine Brain tumors are a major class of pediatric cancers. These tumors arise in the cranium or central spinal canal. Because of the limited space of the intracranial cavity,
CHANGE A LIFE TODAY
As long as poverty, injustice & inequality persist, none of us can truly rest. It doesn’t take much to change a life, Get in touch today and start making the difference.